Aevitas Capital

Aevitas Capital is a specialized venture capital firm focused on advancing human health by investing in innovative life sciences and biotechnology companies. Founded by a team of pioneering gene therapy scientist-entrepreneurs and seasoned investors, the firm leverages its deep scientific and operational expertise to support its portfolio companies. Aevitas employs a data-driven and evidence-based investment approach, aiming to build and scale companies with the potential to deliver transformative therapies for patients with genetic diseases.